TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT04007978 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT05276713 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05276713 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01665417 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04469153 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04469153 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01923077 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01427374 — Predictive Biomarker (PRD): SLC25A20 mRNA
Genes: SLC25A20; CAC; CACT
Study NCT01010477 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT01271439 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00829205 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00786734 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT03613844 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT05399251 — Surrogate Endpoint (SUR): Serum calcium
Study NCT01150747 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01150747 — Predictive Biomarker (PRD): HSPD1 mRNA
Genes: HSPD1; HSP60
Study NCT01996033 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01968759 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01968759 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT04234750 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04234750 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04234750 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT04234750 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00062283 — Predictive Biomarker (PRD): MTAP mRNA
Genes: MTAP; MSAP
Study NCT03771157 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT04638933 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01550289 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03963037 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04694742 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02631421 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT04397523 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03561142 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT03856892 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03703713 — Surrogate Endpoint (SUR): Serum sodium
Study NCT00050856 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02746822 — Predictive Biomarker (PRD): SERPINA5 mRNA
Genes: SERPINA5; PCI; PLANH3; PROCI
Study NCT05714787 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00134082 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02661659 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT02661659 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02661659 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT02385825 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05386810 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03478930 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT01970215 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study NCT01970215 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01970215 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00149162 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01916122 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT01916122 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03059862 — Predictive Biomarker (PRD): AHR mRNA
Genes: AHR; BHLHE76
Study NCT04002726 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study NCT04592549 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03839706 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04465474 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03743662 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT00995553 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT03006016 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT03006016 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02837445 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00119106 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00730132 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00512603 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT03655509 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT02432560 — Predictive Biomarker (PRD): TSC2
Genes: tuberin; LAM; PPP1R160
Study NCT00398541 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00356473 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT00356473 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03128619 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03128619 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04113109 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04590222 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01488864 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT02677363 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02677363 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02037997 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04173988 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01512745 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01831648 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT04095572 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT04095572 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00437021 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01930266 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04228952 — Predictive Biomarker (PRD): CYP2A6 mRNA
Genes: CYP2A6; CYP2A3
Study NCT02820142 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT00530946 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00530946 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03411213 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02415686 — Predictive Biomarker (PRD): SCN1A mRNA
Genes: SCN1A; NAC1; SCN1
Study NCT00166010 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT00773760 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT00048321 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00491816 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT00064558 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04490850 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03675100 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT03675100 — Predictive Biomarker (PRD): GDNF mRNA
Genes: GDNF
Study NCT03675100 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00502047 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03281109 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03281109 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03164603 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT04423926 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02621775 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT03600571 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03429348 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00118677 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02025764 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT04696419 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00358683 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00851370 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00851370 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT01613027 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02947503 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01652079 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01652079 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study NCT01652079 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT01626664 — Predictive Biomarker (PRD): CCR4 mRNA
Genes: CCR4; CMKBR4
Study NCT00067665 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02859454 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05015244 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT03836209 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT02989714 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04119921 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02439138 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01698515 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02600923 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02600923 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02600923 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04180046 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT04180046 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT04180046 — Predictive Biomarker (PRD): ATRX mRNA
Genes: ATRX; RAD54L; XH2
Study NCT03695926 — Predictive Biomarker (PRD): KDM1A mRNA
Genes: KDM1A; AOF2; KDM1; KIAA0601; LSD1
Study NCT01793896 — Predictive Biomarker (PRD): UCP1 mRNA
Genes: UCP1; SLC25A7; UCP
Study NCT01793896 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT01793896 — Predictive Biomarker (PRD): PPARGC1B mRNA
Genes: PPARGC1B; PERC; PGC1; PGC1B; PPARGC1
Study NCT01793896 — Predictive Biomarker (PRD): UCP3 mRNA
Genes: UCP3; SLC25A9
Study NCT01793896 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT01793896 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT01793896 — Safety Biomarker (SAF): Interleukin 1
Study NCT01793896 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01793896 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT00000883 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00369590 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03237819 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study NCT03237819 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT03239132 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PSD mRNA
Genes: PSD; EFA6; EFA6A; KIAA2011; PSD1; TYL
Study NCT01273181 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00527423 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04892979 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00977288 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01653665 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01653665 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04683523 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00592046 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03047915 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02974075 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01386580 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02912910 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02497456 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03037775 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02099578 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02833038 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02036697 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02469298 — Predictive Biomarker (PRD): CXCR2 mRNA
Genes: CXCR2; IL8RB
Study NCT02469298 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CXCL1 mRNA
Genes: CXCL1; GRO; GRO1; GROA; MGSA; SCYB1
Study NCT00699322 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04332302 — Predictive Biomarker (PRD): SPDEF mRNA
Genes: SPDEF; PDEF; PSE
Study NCT00322491 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02619552 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02728609 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01503645 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT01503645 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT01503645 — Predictive Biomarker (PRD): NR1I2
Genes: ONR1; PXR; BXR; SXR; PAR2
Study NCT01503645 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT00900081 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT01305096 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03305029 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT01683175 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01683175 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00386048 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00791713 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT01205607 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02090608 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT05375409 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT01948297 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT01161693 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01178957 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01227434 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT04455113 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT04002713 — Predictive Biomarker (PRD): AMT mRNA
Genes: AMT; GCST
Study NCT02126020 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03047226 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT00926406 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02952573 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study NCT02952573 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04472390 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02296775 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT02792205 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT01363284 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT04338867 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01204086 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03048162 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02165215 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05002062 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05002062 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT03994224 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03994224 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03222336 — Predictive Biomarker (PRD): GLA
Genes: GALA
Study NCT02516800 — Predictive Biomarker (PRD): SLC34A2 mRNA
Genes: SLC34A2
Study NCT02516800 — Predictive Biomarker (PRD): SLC34A3 mRNA
Genes: SLC34A3; NPT2C; NPTIIC
Study NCT02516800 — Predictive Biomarker (PRD): SLC20A1 mRNA
Genes: SLC20A1; GLVR1; PIT1
Study NCT05498896 — Predictive Biomarker (PRD): AKT1 mRNA
Genes: AKT1; PKB; RAC
Study NCT05498896 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT00307060 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03510832 — Predictive Biomarker (PRD): SERPINA5 mRNA
Genes: SERPINA5; PCI; PLANH3; PROCI
Study NCT03505853 — Predictive Biomarker (PRD): AIP mRNA
Genes: AIP; XAP2
Study NCT01668888 — Predictive Biomarker (PRD): C1QTNF3 mRNA
Genes: C1QTNF3; CTRP3; UNQ753/PRO1484
Study NCT02115906 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT00006222 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT03782818 — Predictive Biomarker (PRD): PARP1 mRNA
Genes: PARP1; ADPRT; PPOL
Study NCT00748059 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03572270 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT01387295 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03254251 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02787577 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01540240 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03783208 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01023074 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study NCT02848872 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study NCT02848872 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT04112537 — Predictive Biomarker (PRD): TSC1
Genes: KIAA0243; LAM; hamartin
Study NCT04112537 — Predictive Biomarker (PRD): TSC2
Genes: tuberin; LAM; PPP1R160
Study NCT00297830 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02166359 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT03725202 — Predictive Biomarker (PRD): GCA mRNA
Genes: GCA; GCL
Study NCT04797819 — Predictive Biomarker (PRD): IL1RL1 mRNA
Genes: IL1RL1; DER4; ST2; T1
Study NCT03593993 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT02478632 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00786500 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03473977 — Predictive Biomarker (PRD): IL5RA mRNA
Genes: IL5RA; IL5R
Study NCT01445561 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02753868 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01847274 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT02363036 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT02363036 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study NCT02124083 — Predictive Biomarker (PRD): NPC1 mRNA
Genes: NPC1
Study NCT02124083 — Predictive Biomarker (PRD): NPC2 mRNA
Genes: NPC2; HE1
Study NCT01210456 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00847379 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT00847379 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study NCT05094583 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT01574248 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01728012 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT01728012 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT01454011 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT00828425 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02256813 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT02256813 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT02256813 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT02256813 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT03653845 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03653845 — Surrogate Endpoint (SUR): Serum potassium
Study NCT06062082 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01896102 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34